Biogenic synthesis of silver nanoparticles using pigment producing Streptomyces sp and Its drug binding assay

Santhanalakshmi Krishnamoorthy¹ , Natarajan Ekambaram²

1. Department of Biotechnology, National College (Autonomous), Tiruchirappalli, India.
2. Department of Biotechnology, National College (Autonomous), Tiruchirappalli, India.

Section:Research Paper, Product Type: Isroset-Journal
Vol.5 , Issue.5 , pp.102-107, Oct-2018

CrossRef-DOI:   https://doi.org/10.26438/ijsrbs/v5i5.102107

Online published on Oct 31, 2018

Copyright © Santhanalakshmi Krishnamoorthy, Natarajan Ekambaram . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

442 Views    239 Downloads    157 Downloads

Abstract :
Cardiovascular disease, management of hypertension is mostly treated by Amlodipine, atorvastatin and telmisartan. Amikacin also one of the pharmaceutical drugs against bacterial infections. The Streptomyces sp. DSK2 melanin absorbs the drugs in different concentration, different temperature and different incubation timings. The result shows that the Streptomyces sp. DSK2melanin absorb the drugs in 40◦C and the reaction timings were 180min. Amlodopine bind strongly at 40◦C at180 min, other two drugs Atorvastatin and Amikacin moderate bind at 40◦C at 120 min. Other biomedical studies of the Streptomyces sp. DSK2 melanin silver nanoprticle was synthesized in 180s by the microwave radiation method. The silver nanoparticle range 50nm in size, which is confirmed by TEM analysis, UV spectrum at 420nm , FTIR Spectrum , XRD. The melanin showed the potent antioxidant activity was determined by DPPH assay, the maximum activity was 87.96 and the total antioxidant activity phosphomolybdate assay) was 88.05. in this study , Streptomyces sp. DSK2 Melanin has great biomedical activity.

Key-Words / Index Term :
Drug, Streptomyces sp., Melanin, microwave radiation, silver nanoparticles

References :
[1]. Larsson B.S.: “Pigment Cell Res”- 6, 127 (1993).
[2]. Hong L., Simon J.D.: J. Phys. Chem. B. 111, 7938 (2007).
[3]. Liu, Y. T., M. J. Sui, D. D. Ji, I. H. Wu, C. Chou, and C. C. Chen. “Protection from UV irradiation by melanin of mosquitocidal activity of Bt. var. Israeliensis”. J. Invertebr. Pathol. 62: 131-136. 1993.
[4]. Larsson BS , “Interaction between chemicals and melanin”. Pigment Cell Res 6:127–133.
[5]. Zane P, Brindle SD, Gause D, O’Buck AJ, Raghavan PR, Tripp SL, “Physicochemical factors associated with binding and retention of compounds in ocular melanin of rats: correlations using data from whole-body autoradiography and molecular modeling for multiple linear regression analyses”. Pharm Res 7:935–941, 1990
[6]. Atlasik B, Stephen K, Wilczok T ,” Interaction of drugs with ocular melanin in vitro”. Exp Eye Res 30:pp 325–33,1980
[7]. Debing I, Ijzerman AP, Vauqelin G, “Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity”. Mol Pharmacol 33:470–476, 1988
[8]. Shimada K, Baweja R, Sokoloski T, Patil PN, “ Binding characteristics of drugs to synthetic levodopa melanin”. J Pharm Sci 65:1057–1060, 1976.
[9]. Buszman E., Wrzeuniok D., Trzcionka J.: Pharmazie 62, 210 ,2007.
[10]. Wrzeuniok D., Buszman E., Karna E., Paka J.: Pharmazie 60, 439 (2005).
[11]. Wrzeuniok D., Buszman E., Lakota D.: Acta Pol. Pharm. Drug Res. 68, 493 (2011).
[12]. M.M. Salazar-Bookaman, I. Wainer, P.N. Patil, J. Ocul. Pharmacol. Vol.10 , 217-220 ,1994.
[13]. N.G. Lindquist, S. Ullberg, Acta Pharmacol. Toxicol (Copenh.) 2(Suppl) 1972.
[14]. Nordberg G.F., Fowler B.A., Nordberg M.,Friberg L.: “Handbook on the Toxicology of
[15]. Metals”. 3rd edition., pp. 6- 8, Elsevier, Amsterdam 2007.
[16]. Huang J, Chen C, He N, Hong J, Lu Y, Qingbiao L, Shao W, Sun D, Wang XH, Wang Y, Yiang,“Biosynthesis of silver and gold nanoparticles by novel sundried Cinnamomum camphora Leaf”. Nanotechnology Issue-18: pp-105–106., 2007.
[17]. Rai M, Yadav A, Gade A, “Current trends in phytosynthesis of metal nanoparticles. Crit Rev
[18]. Biotechnology”. 28(4):277–284, 2008
[19]. Husseiny MI, El-Aziz MA, Badr Y, Mahmoud MA,”Biosynthesis of gold nanoparticles
[20]. using Pseudomonas aeruginosa”. Spectrochim Acta A: Mol Biomol Spectrosc 67: pp- 1003–1006, 2007.
[21]. Shahverdi AR, Minaeian S, Shahverdi HR, Jamalifar H, Nohi AA, “Rapid synthesis of silver
[22]. nanoparticles using culture supernatants of Enterobacteria: a novel biological approach”.
[23]. Process Biochem 42: pp-919–923, 2007.
[24]. Kumar V, Yadav SK ,”Plant-mediated synthesis of silver and gold nanoparticles and their
[25]. Applications”. J Chem Technol Biotechnol 84:pp- 151–157, 2009.
[26]. Parikh RY, Singh S, Prasad BLV, Patole MS, Sastry M, Shouche YS, “Extracellular synthesis of crystalline silver nanoparticles and molecular evidence of silver resistance from Morganella sp: towards understanding biochemical synthesis mechanism”. ChemBioChem .9:pp- 1415–1422, 2008.
[27]. Gajbhiye M, Kesharwani J, Ingle A, Gade A, Rai M, “Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole.Nanomed” Nanotechnol Biol Med vol-5:pp-382–386.2009.
[28]. Ahmad A, Senapati S, Khan MI, Kumar R, Ramani R, Shrinivas V, Sastry M,”Intracellular synthesis of gold nanoparticles by a novel alkalotolerant actinomycete, Rhodococcus species”.Nanotechnology vol-14:pp-824–828, 2003b.
[29]. Shahi SK, Patra M, “Microbially synthesized bioactive nanoparticles and their formulation active against human pathogenic fungi". Rev Adv Mater Sci 5:501–509, 2003.
[30]. Singaravelu G, Arockiamary JS, Ganesh Kumar V, Govindraju K, “A novel extracellular synthesis of monodisperse gold nanoparticles using marine alga, Sargassum wightii Greville”.Colloid Surf B: Biointerface 57: pp-97–101, 2007.
[31]. Chakraborty N, Banerjee A, Lahiri S, Panda A, Ghosh AN, Pal R, “Biorecovery of gold using cyanobacteria and eukaryotic alga with special reference to nanogold formation – a novel phenomenon”. J Appl Phycol 21(1):145–152, 2009.
[32]. Gade AK, Bonde P, Ingle AP, Marcato PD, Duran N, Rai MK, “Exploitation of Aspergillus niger for synthesis of silver nanoparticles". J Biobased Mater Bioenergy 2:pp- 243–247, 2008.
[33]. Mukherjee P, Ahmad A, Mandal D, Senapati S, Sainkar SR, Khan MI, Ramani R, Parischa R, Ajayakumar PV, Alam M, Sastry M, Kumar R ,”Bioreduction of AuCl4ions by the fungus Verticillium sp and surface trapping of the gold nanoparticles formed”. Angew Chem Int Ed 40(19): pp-3585–3588, 2001.
[34]. J. Gallas, M. Eisner, Melanin polyvinyl alcohol plastic laminates for optical applications, US Patent7029758 , 2006.